Product Images Losartan Potassium

This is a description of Losartan Potassium Tablets, USP 50mg, with package details such as NDC number, lot number, and expiry date. It also includes dosage information, storage recommendations, and a warning to keep it out of the reach of children. The text confirms that these tablets are for prescription use only and are repackaged by a company called Northwind Pharm in NY.*

This appears to be a partial graph or figure with two medication names (Atenolol and Losartan Potassium) and a statistic labeled "Adjusted Risk Reduction" of 13% with a p-value that cannot be discerned from the text. The x-axis is labeled in months (up to 66 months) and it is unclear what the y-axis represents. Without further context, it is not possible to provide a more accurate description of this text.*

This is a statistical table presenting the occurrence of primary endpoint events related to demographic subgroups which include gender, race, age, history of VD, and other factors. There is information about the total sample size and the number of events for each category. However, the content and context of the study are not available from this text.*

This appears to be a graph or table displaying data about a medical treatment involving Losttan Potassium and a placebo. It shows the percentage of patients with an event, with 60% of patients experiencing an event with Losttan Potassium and 40% with the placebo. The "Risk Reduction" is listed as 16.1% and there is a p-value of 0.022, which may indicate statistical significance. The meaning of the events and the nature of the treatment is not available without further context.*